Global Dermatology Devices Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Dermatology Devices Market Size

• The global dermatology devices market size was valued at USD 17.11 billion in 2024 and is expected to reach USD 39.71 billion by 2032, at a CAGR of 11.10% during the forecast period
• This growth is driven by factors such as the increasing prevalence of skin disorders, rising demand for aesthetic procedures, technological advancements in dermatology devices, and the growing aging population

Dermatology Devices Market Analysis

• The increasing occurrence of skin diseases such as non-melanoma skin cancer and melanoma, vascular and pigmented lesions, psoriasis, varicose veins, and acne coupled with growing responsiveness among the patient populace have activated the market for dermatology treatment and diagnostic devices. Vascular lesions, a common skin ailment in emerging economies, have the highest occurrence
• Thus, high prevalence would completely impression the growth of dermatology diagnostic devices. On the other hand, the growing demand for aesthetic surgeries is pushing up the market for treatment devices
• North America is expected to dominate the dermatology devices market with 43.5% due to advanced healthcare infrastructure and increasing prevalence of skin cancer and other skin diseases 
• Asia-Pacific is expected to be the fastest growing region in the dermatology devices market during the forecast period due to affordable treatment options is expected to increase the market growth
• Treatment devices segment is expected to dominate the market with a market share of 78.22% due to the increasing demand for both surgical and non-surgical cosmetic procedures, such as laser treatments, skin rejuvenation, and body contouring

Report Scope and Dermatology Devices Market Segmentation        

Dermatology Devices Market Trends

“Integration of Artificial Intelligence (AI) and Machine Learning (ML) in Dermatology Devices”

• The integration of Artificial Intelligence (AI) and Machine Learning (ML) into dermatology devices is revolutionizing the field by enhancing diagnostic accuracy and treatment precision
• AI algorithms can analyze skin images to detect conditions such as melanoma, acne, and psoriasis with high accuracy, often matching or surpassing human dermatologists 
  • For instance, AI-powered tools such as DermEngine and FirstDerm facilitate remote consultations, allowing dermatologists to evaluate skin conditions through digital images, thus improving access to care, especially in underserved regions
• These advancements not only streamline workflows but also enable personalized treatment plans, leading to better patient outcomes

Dermatology Devices Market Dynamics

Driver

“Increasing Prevalence of Skin Disorders”

• The rising incidence of skin disorders, including acne, eczema, and skin cancer, is a significant driver of the global dermatology devices market
•  This surge in skin disorders is prompting healthcare providers to adopt advanced diagnostic and treatment devices to manage and treat these conditions effectively
• Additionally, the growing awareness and early detection initiatives are encouraging individuals to seek dermatological care, further boosting the demand for specialized devices

Opportunity

“Expansion in Emerging Markets”

• Emerging markets present a significant opportunity for growth in the dermatology devices sector
• Regions such as Asia-Pacific are experiencing rapid economic development, leading to increased disposable incomes and a greater focus on healthcare. This shift is driving demand for both medical and aesthetic dermatology devices 
  • For Instance, private-equity firm ArchiMed's acquisition of Jeisys Medical, a Korean producer of energy-based devices, underscores the growing interest in the Asian aesthetic healthcare market
• Companies expanding into these regions can capitalize on the rising middle class and the increasing emphasis on skin health and beauty

Restraint/Challenge

“Regulatory Hurdles and Supply Chain Disruptions”

• Despite the market's growth, dermatology device manufacturers face significant challenges, including stringent regulatory requirements and supply chain disruptions
• Obtaining approvals for new devices involves navigating complex regulatory landscapes, which can delay product launches and increase costs
• Additionally, geopolitical tensions, such as the U.S.-China trade war, have disrupted global supply chains, leading to higher costs and potential shortages of essential components such as medical-grade metals and polymers
• These challenges can hinder the timely delivery of products and affect the overall market growth

Dermatology Devices Market Scope

The market is segmented on the basis of product type, application, and end user

In 2025, the treatment devices is projected to dominate the market with a largest share in product type segment

The treatment devices segment is expected to dominate the dermatology devices market with the largest share of 78.22% in 2025 due to the increasing demand for both surgical and non-surgical cosmetic procedures, such as laser treatments, skin rejuvenation, and body contouring. The growing emphasis on aesthetics, particularly among the aging population and those seeking cosmetic enhancements, has significantly contributed to the demand for treatment devices.

The skin cancer diagnosis is expected to account for the largest share during the forecast period in application market

In 2025, the skin cancer diagnosis segment is expected to dominate the market with the largest market share due to the increasing prevalence of skin cancer, particularly melanoma, has heightened the demand for early and accurate diagnostic tools. Devices such as dermatoscopes and imaging systems are essential in identifying malignant and benign lesions, contributing to the segment's growth.

Dermatology Devices Market Regional Analysis

“North America Holds the Largest Share in the Dermatology Devices Market”

• North America held a significant share of the global dermatology devices market with 43.5%, driven by high demand for both medical and aesthetic dermatology treatments ​
• The region faces a substantial burden of skin conditions, including skin cancer, acne, and eczema, contributing to increased demand for dermatology devices ​
• The presence of leading industry players and continuous innovation in dermatology devices support market growth
• Increased healthcare expenditure and favorable reimbursement policies enhance the accessibility and adoption of dermatology devices ​
• Rising consumer interest in cosmetic procedures further drives the demand for dermatology devices in the region ​

“Asia-Pacific is Projected to Register the Highest CAGR in the Dermatology Devices Market”

• Rising incidences of skin conditions in countries such as India and China are driving the demand for dermatology devices ​
• Growing awareness and adoption of advanced dermatology devices contribute to market growth ​
• Streamlined regulatory processes in countries such as India and China facilitate the introduction of new dermatology devices
• Rising disposable incomes and improved healthcare infrastructure in the region support the demand for dermatology devices ​

Dermatology Devices Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

The Major Market Leaders Operating in the Market Are:

• Bausch Health Companies Inc. (Canada)
• Cynosure Inc. (U.S.)
• Candela Medical. (U.S.)
• Avita Medical (U.S.)
• Shanghai Fosun Pharmaceutical (Group) Co. Ltd. (China)
• Lutronic (South Korea)
• Beijing Toplaser Technology Co. Ltd. (China)
• Cynosure, LLC (U.S.)
• Solta Medical (U.S.)
• Cutera (U.S.)
• Candela Medical Ltd. (U.S.)
• Canfield Scientific, Inc. (U.S.)
• 3Gen Consulting (U.S.)
• Image Derm, Inc. (U.S.)
• Agilent Technologies Inc. (U.S.)

Latest Developments in Global Dermatology Devices Market

• In July 2023, Canfield Scientific had announced the 25th World Congress of Dermatology, which was held from the 4th to the 7th of July at the Suntec Singapore Convention & Exhibition Centre. It comprised in-person demonstrations of its advanced and latest dermatology devices and solutions, including IntelliStudio, VEOS, DermaGraphix, and VECTRA WB360
• In June 2023, Hoag Hospital in the U.S. introduced the VECTRA WB360, the world's first whole-body 3D photographic imaging system. This system employs 92 cameras to capture a patient's entire skin surface in less than a second, creating a 3D avatar mapping all moles and lesions with high-resolution fidelity
• In April 2023, Canfield Scientific was certified to both ISO 9001:2015 and ISO 13485:2016 standards for its quality management system
• In February 2023, Candela Corporation, a global manufacturer of medical aesthetic devices announced that the dual-wavelength Frax Pro non-ablative fractional laser platform and the Nordlys multi-application platform with Selective Waveband Technology (SWT) were licensed and made available by Health Canada
• In January 2021, Casio Computer Co., Ltd. announced the upcoming release of the DZ-D100 DERMOCAMERA that allows close-up shots with the lens directly touching the skin as well as ordinary shots, all using a single camera    

SKU-943